Biotechnology
The Biotechnology industry has a total of 677 stocks, with a combined market cap of $848.02 billion and total revenue of $94.94 billion.
Market Cap
848.02B
Revenue
94.94B
Profits
-47.85B
PE Ratio
n/a
Profit Margin
-50.40%
Dividend Yield
0.04%
662 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 129.05B | 0.45% | 1,228,964 | 11.02B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 68.05B | -0.67% | 773,222 | 14.20B |
| 3 | ARGX | argenx SE | 36.33B | 1.68% | 310,119 | 2.25B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 35.09B | 0.67% | 898,707 | 2.25B |
| 5 | ONC | BeiGene, Ltd. | 28.24B | 4.65% | 618,992 | 3.81B |
| 6 | BNTX | BioNTech SE | 22.89B | -0.52% | 700,283 | 2.85B |
| 7 | RPRX | Royalty Pharma plc | 18.24B | 0.29% | 7,255,102 | 2.26B |
| 8 | SMMT | Summit Therapeutics Inc. | 15.20B | 3.57% | 1,628,420 | - |
| 9 | INSM | Insmed Incorporated | 14.06B | 1.46% | 968,225 | 363.71M |
| 10 | BMRN | BioMarin Pharmaceutical Inc. | 13.89B | 1.89% | 1,307,717 | 2.85B |
| 11 | UTHR | United Therapeutics Corporation | 13.83B | -0.90% | 296,692 | 2.88B |
| 12 | GMAB | Genmab A/S | 12.87B | 2.65% | 1,009,706 | 2.99B |
| 13 | MRNA | Moderna, Inc. | 12.42B | 2.03% | 5,476,898 | 3.24B |
| 14 | INCY | Incyte Corporation | 11.74B | -0.95% | 1,244,432 | 4.24B |
| 15 | EXEL | Exelixis, Inc. | 10.31B | -0.46% | 2,679,581 | 2.17B |
| 16 | TECH | Bio-Techne Corporation | 9.48B | 0.96% | 1,461,267 | 1.20B |
| 17 | ASND | Ascendis Pharma A/S | 9.45B | -0.21% | 264,849 | 376.48M |
| 18 | PCVX | Vaxcyte, Inc. | 9.11B | 3.22% | 867,871 | - |
| 19 | HALO | Halozyme Therapeutics, Inc. | 7.94B | 1.03% | 628,580 | 1.02B |
| 20 | JAZZ | Jazz Pharmaceuticals plc | 7.68B | -3.42% | 1,456,426 | 4.07B |
| 21 | ROIV | Roivant Sciences Ltd. | 7.48B | 0.38% | 4,215,005 | 122.59M |
| 22 | MDGL | Madrigal Pharmaceuticals, Inc. | 7.45B | 1.03% | 124,671 | 180.13M |
| 23 | RVMD | Revolution Medicines, Inc. | 7.08B | 1.01% | 705,001 | - |
| 24 | SRPT | Sarepta Therapeutics, Inc. | 6.97B | -1.47% | 1,364,422 | 1.90B |
| 25 | BBIO | BridgeBio Pharma, Inc. | 6.92B | 0.83% | 1,280,117 | 221.90M |
| 26 | LEGN | Legend Biotech Corporation | 6.50B | 2.08% | 667,654 | 627.24M |
| 27 | CORT | Corcept Therapeutics Incorporated | 5.98B | -0.75% | 431,085 | 675.04M |
| 28 | AXSM | Axsome Therapeutics, Inc. | 5.94B | 2.19% | 495,785 | 385.69M |
| 29 | TLX | Telix Pharmaceuticals Limited | 5.87B | -4.32% | 16,418 | 484.69M |
| 30 | TGTX | TG Therapeutics, Inc. | 5.84B | -1.45% | 1,281,072 | 329.00M |
| 31 | BPMC | Blueprint Medicines Corporation | 5.73B | -1.09% | 651,723 | 508.82M |
| 32 | VRNA | Verona Pharma plc | 5.48B | 0.51% | 871,730 | 42.28M |
| 33 | NUVL | Nuvalent, Inc. | 5.27B | -0.42% | 472,787 | - |
| 34 | KRYS | Krystal Biotech, Inc. | 5.26B | -2.32% | 280,219 | 290.52M |
| 35 | CYTK | Cytokinetics, Incorporated | 5.09B | -1.47% | 1,915,602 | 18.47M |
| 36 | IONS | Ionis Pharmaceuticals, Inc. | 5.04B | 0.73% | 1,151,299 | 705.14M |
| 37 | ADMA | ADMA Biologics, Inc. | 4.82B | 2.94% | 2,278,992 | 426.45M |
| 38 | PTCT | PTC Therapeutics, Inc. | 4.34B | -0.58% | 379,449 | 806.78M |
| 39 | RNA | Avidity Biosciences, Inc. | 3.91B | 1.59% | 832,590 | 10.90M |
| 40 | ZLAB | Zai Lab Limited | 3.89B | 6.69% | 795,345 | 398.99M |
| 41 | ACLX | Arcellx, Inc. | 3.76B | -2.28% | 365,689 | 107.94M |
| 42 | RARE | Ultragenyx Pharmaceutical Inc. | 3.60B | 2.40% | 533,846 | 560.23M |
| 43 | SWTX | SpringWorks Therapeutics, Inc. | 3.56B | 2.17% | 994,994 | 191.59M |
| 44 | AKRO | Akero Therapeutics, Inc. | 3.47B | 0.67% | 441,147 | - |
| 45 | RYTM | Rhythm Pharmaceuticals, Inc. | 3.38B | -1.49% | 486,299 | 130.13M |
| 46 | CRSP | CRISPR Therapeutics AG | 3.26B | -2.91% | 1,560,384 | 37.31M |
| 47 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.25B | 1.13% | 367,447 | 1.04M |
| 48 | IMVT | Immunovant, Inc. | 3.19B | 5.03% | 1,145,576 | - |
| 49 | SRRK | Scholar Rock Holding Corporation | 3.16B | 3.73% | 1,020,365 | - |
| 50 | MTSR | Metsera, Inc. | 3.15B | 6.76% | 315,648 | - |
| 51 | MRUS | Merus N.V. | 3.10B | 0.85% | 381,405 | 36.13M |
| 52 | SLNO | Soleno Therapeutics, Inc. | 3.09B | 37.61% | 14,906,308 | - |
| 53 | APLS | Apellis Pharmaceuticals, Inc. | 3.05B | 2.06% | 2,602,852 | 781.37M |
| 54 | PTGX | Protagonist Therapeutics, Inc. | 3.03B | -0.24% | 666,688 | 434.43M |
| 55 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.02B | -1.23% | 900,637 | 491.73M |
| 56 | VKTX | Viking Therapeutics, Inc. | 2.93B | -0.80% | 2,477,152 | - |
| 57 | BHVN | Biohaven Ltd. | 2.90B | -1.63% | 603,583 | - |
| 58 | IBRX | ImmunityBio, Inc. | 2.87B | 20.86% | 15,752,283 | 14.75M |
| 59 | ACAD | ACADIA Pharmaceuticals Inc. | 2.87B | 0.94% | 740,216 | 957.80M |
| 60 | FOLD | Amicus Therapeutics, Inc. | 2.64B | 0.82% | 2,033,149 | 528.30M |
| 61 | XENE | Xenon Pharmaceuticals Inc. | 2.64B | -0.92% | 307,249 | - |
| 62 | MLTX | MoonLake Immunotherapeutics | 2.52B | 3.78% | 795,776 | - |
| 63 | NAMS | NewAmsterdam Pharma Company N.V. | 2.46B | -0.66% | 822,465 | 45.56M |
| 64 | RXRX | Recursion Pharmaceuticals, Inc. | 2.40B | -3.24% | 13,809,976 | 58.84M |
| 65 | VCEL | Vericel Corporation | 2.30B | -0.75% | 414,894 | 237.22M |
| 66 | APGE | Apogee Therapeutics, Inc. | 2.28B | -2.22% | 461,496 | - |
| 67 | MIRM | Mirum Pharmaceuticals, Inc. | 2.26B | -0.43% | 524,539 | 336.89M |
| 68 | EWTX | Edgewise Therapeutics, Inc. | 2.23B | 5.30% | 1,630,674 | - |
| 69 | BLTE | Belite Bio, Inc | 2.13B | 2.51% | 56,063 | - |
| 70 | LGND | Ligand Pharmaceuticals Incorporated | 2.11B | 1.49% | 131,089 | 167.13M |
| 71 | DNLI | Denali Therapeutics Inc. | 2.06B | 2.82% | 653,725 | - |
| 72 | CGON | CG Oncology, Inc. | 2.05B | 1.51% | 462,519 | 684.00K |
| 73 | KYMR | Kymera Therapeutics, Inc. | 1.96B | -0.63% | 211,744 | 47.07M |
| 74 | TARS | Tarsus Pharmaceuticals, Inc. | 1.94B | -0.71% | 413,158 | 182.95M |
| 75 | CNTA | Centessa Pharmaceuticals plc | 1.93B | -0.21% | 674,763 | - |
| 76 | HRMY | Harmony Biosciences Holdings, Inc. | 1.91B | 0.42% | 308,639 | 714.73M |
| 77 | ARQT | Arcutis Biotherapeutics, Inc. | 1.91B | -2.31% | 1,421,904 | 196.54M |
| 78 | IRON | Disc Medicine, Inc. | 1.81B | -0.04% | 182,758 | - |
| 79 | TVTX | Travere Therapeutics, Inc. | 1.81B | -2.02% | 1,118,031 | 233.18M |
| 80 | BEAM | Beam Therapeutics Inc. | 1.80B | 1.28% | 932,094 | 63.52M |
| 81 | AGIO | Agios Pharmaceuticals, Inc. | 1.77B | 1.45% | 459,871 | 36.50M |
| 82 | AAPG | Ascentage Pharma Group International | 1.76B | 9.96% | 51,814 | 134.35M |
| 83 | JANX | Janux Therapeutics, Inc. | 1.76B | -1.13% | 766,897 | 10.59M |
| 84 | ARWR | Arrowhead Pharmaceuticals, Inc. | 1.74B | -0.93% | 1,349,989 | 2.50M |
| 85 | MESO | Mesoblast Limited | 1.72B | -3.97% | 253,641 | 5.67M |
| 86 | VERA | Vera Therapeutics, Inc. | 1.69B | 2.35% | 759,625 | - |
| 87 | GLPG | Galapagos NV | 1.68B | 1.47% | 133,956 | 285.38M |
| 88 | MNKD | MannKind Corporation | 1.55B | 0.79% | 1,266,602 | 285.50M |
| 89 | IDYA | IDEAYA Biosciences, Inc. | 1.53B | -0.06% | 770,062 | 7.00M |
| 90 | IMCR | Immunocore Holdings plc | 1.51B | 2.17% | 555,081 | 310.20M |
| 91 | BTX | BlackRock Innovation and Growth Term Trust | 1.41B | -1.68% | 609,850 | - |
| 92 | WVE | Wave Life Sciences Ltd. | 1.38B | -10.08% | 1,710,475 | 108.30M |
| 93 | DYN | Dyne Therapeutics, Inc. | 1.33B | 4.80% | 1,436,530 | - |
| 94 | CLDX | Celldex Therapeutics, Inc. | 1.33B | 2.10% | 538,645 | 7.02M |
| 95 | ETNB | 89bio, Inc. | 1.31B | 11.72% | 3,782,840 | - |
| 96 | LQDA | Liquidia Corporation | 1.30B | 2.49% | 407,012 | 14.00M |
| 97 | SPRY | ARS Pharmaceuticals, Inc. | 1.24B | 0.24% | 1,533,963 | 89.15M |
| 98 | OCUL | Ocular Therapeutix, Inc. | 1.23B | 1.04% | 1,786,085 | 63.72M |
| 99 | ARDX | Ardelyx, Inc. | 1.23B | 1.98% | 4,936,148 | 333.62M |
| 100 | ADPT | Adaptive Biotechnologies Corporation | 1.22B | -0.24% | 2,516,161 | 178.96M |
| 101 | VRDN | Viridian Therapeutics, Inc. | 1.20B | 3.53% | 556,215 | 302.00K |
| 102 | IOVA | Iovance Biotherapeutics, Inc. | 1.19B | 5.52% | 6,756,283 | 164.07M |
| 103 | NVAX | Novavax, Inc. | 1.17B | -1.76% | 2,386,880 | 682.16M |
| 104 | SNDX | Syndax Pharmaceuticals, Inc. | 1.17B | 3.27% | 827,259 | 23.68M |
| 105 | AUPH | Aurinia Pharmaceuticals Inc. | 1.16B | -0.70% | 765,402 | 235.13M |
| 106 | GPCR | Structure Therapeutics Inc. | 1.14B | -0.30% | 585,401 | - |
| 107 | MDXG | MiMedx Group, Inc. | 1.14B | 1.31% | 472,436 | 348.88M |
| 108 | INVA | Innoviva, Inc. | 1.12B | 2.64% | 1,162,350 | 358.71M |
| 109 | SYRE | Spyre Therapeutics, Inc. | 1.07B | 3.82% | 773,113 | - |
| 110 | ELVN | Enliven Therapeutics, Inc. | 1.05B | 4.66% | 161,633 | - |
| 111 | GERN | Geron Corporation | 1.05B | -2.94% | 11,856,341 | 76.99M |
| 112 | OCS | Oculis Holding AG | 1.03B | -1.32% | 36,480 | 757.02K |
| 113 | NRIX | Nurix Therapeutics, Inc. | 952.38M | -1.41% | 489,726 | 54.55M |
| 114 | VIR | Vir Biotechnology, Inc. | 914.75M | 1.21% | 1,229,533 | 74.21M |
| 115 | RCUS | Arcus Biosciences, Inc. | 898.02M | 2.72% | 619,646 | 258.00M |
| 116 | ZYME | Zymeworks Inc. | 870.41M | 1.21% | 311,591 | 76.30M |
| 117 | NTLA | Intellia Therapeutics, Inc. | 869.55M | 1.08% | 2,713,750 | 57.88M |
| 118 | XERS | Xeris Biopharma Holdings, Inc. | 866.68M | -1.40% | 3,203,681 | 203.07M |
| 119 | GYRE | Gyre Therapeutics, Inc. | 850.94M | 3.41% | 176,462 | 105.76M |
| 120 | PHVS | Pharvaris N.V. | 844.41M | 0.41% | 18,701 | - |
| 121 | RCKT | Rocket Pharmaceuticals, Inc. | 840.24M | 2.47% | 1,910,130 | - |
| 122 | DAWN | Day One Biopharmaceuticals, Inc. | 830.09M | 0.86% | 706,749 | 131.16M |
| 123 | AVXL | Anavex Life Sciences Corp. | 811.51M | 1.92% | 1,015,446 | - |
| 124 | XNCR | Xencor, Inc. | 811.02M | 4.12% | 935,126 | 110.49M |
| 125 | REPL | Replimune Group, Inc. | 804.80M | 0.48% | 284,783 | - |
| 126 | CMRX | Chimerix, Inc. | 783.78M | -0.23% | 705,754 | 212.00K |
| 127 | PRAX | Praxis Precision Medicines, Inc. | 783.34M | 1.73% | 386,450 | 8.55M |
| 128 | GHRS | GH Research PLC | 759.84M | 1.58% | 206,897 | - |
| 129 | FTRE | Fortrea Holdings Inc. | 754.07M | -1.07% | 1,482,664 | 2.70B |
| 130 | MLYS | Mineralys Therapeutics, Inc. | 747.53M | -7.12% | 1,039,799 | - |
| 131 | LENZ | LENZ Therapeutics, Inc. | 730.71M | 1.69% | 79,482 | - |
| 132 | COGT | Cogent Biosciences, Inc. | 730.66M | 2.16% | 923,174 | - |
| 133 | BCAX | Bicara Therapeutics Inc. | 729.17M | 2.29% | 331,061 | - |
| 134 | QURE | uniQure N.V. | 709.76M | -3.85% | 2,008,978 | 27.12M |
| 135 | ABCL | AbCellera Biologics Inc. | 703.25M | -2.48% | 2,765,185 | 28.83M |
| 136 | PRTA | Prothena Corporation plc | 700.29M | -2.69% | 273,040 | 135.16M |
| 137 | DNTH | Dianthus Therapeutics, Inc. | 638.33M | 8.76% | 197,664 | 6.24M |
| 138 | BCYC | Bicycle Therapeutics plc | 635.97M | 5.27% | 494,153 | 35.28M |
| 139 | NUVB | Nuvation Bio Inc. | 633.33M | -0.53% | 1,471,375 | 7.87M |
| 140 | IMNM | Immunome, Inc. | 633.00M | 2.68% | 1,204,358 | 9.04M |
| 141 | AVBP | ArriVent BioPharma, Inc. | 631.68M | 1.59% | 160,561 | - |
| 142 | TRVI | Trevi Therapeutics, Inc. | 630.85M | 0.85% | 1,169,118 | - |
| 143 | CVAC | CureVac N.V. | 628.08M | -1.75% | 486,647 | 70.57M |
| 144 | ABUS | Arbutus Biopharma Corporation | 619.64M | -2.39% | 1,386,690 | 6.17M |
| 145 | KALV | KalVista Pharmaceuticals, Inc. | 613.49M | 2.24% | 458,082 | - |
| 146 | MRVI | Maravai LifeSciences Holdings, Inc. | 597.69M | -0.84% | 1,672,768 | 259.19M |
| 147 | PHAR | Pharming Group N.V. | 594.83M | -1.44% | 4,420 | 297.20M |
| 148 | VALN | Valneva SE | 587.95M | 1.26% | 16,613 | 175.56M |
| 149 | MGTX | MeiraGTx Holdings plc | 582.74M | 2.21% | 437,336 | 33.28M |
| 150 | SVRA | Savara Inc. | 582.30M | 2.96% | 1,065,064 | - |
| 151 | KURA | Kura Oncology, Inc. | 576.59M | - | 455,631 | 53.88M |
| 152 | NAGE | Niagen Bioscience, Inc. | 575.81M | -3.40% | 584,778 | 99.60M |
| 153 | ANAB | AnaptysBio, Inc. | 571.94M | 2.53% | 1,329,864 | 91.28M |
| 154 | IMTX | Immatics N.V. | 562.17M | 3.97% | 834,179 | 161.34M |
| 155 | ARVN | Arvinas, Inc. | 552.93M | 1.13% | 2,122,523 | 263.40M |
| 156 | CAPR | Capricor Therapeutics, Inc. | 539.66M | -10.36% | 1,766,097 | 22.27M |
| 157 | SAGE | Sage Therapeutics, Inc. | 532.43M | 0.70% | 930,783 | 41.24M |
| 158 | SION | Sionna Therapeutics, Inc. | 528.61M | -0.50% | 162,355 | - |
| 159 | URGN | UroGen Pharma Ltd. | 527.78M | -0.61% | 557,761 | 90.40M |
| 160 | OMER | Omeros Corporation | 516.91M | 4.69% | 666,978 | - |
| 161 | TYRA | Tyra Biosciences, Inc. | 508.15M | -5.66% | 312,914 | - |
| 162 | RLAY | Relay Therapeutics, Inc. | 506.87M | 4.55% | 1,667,390 | 10.01M |
| 163 | MAZE | Maze Therapeutics, Inc. | 493.37M | 4.74% | 122,655 | 167.50M |
| 164 | CGEM | Cullinan Therapeutics, Inc. | 485.07M | 2.47% | 232,959 | - |
| 165 | MNMD | Mind Medicine (MindMed) Inc. | 484.62M | -2.28% | 1,288,422 | - |
| 166 | PGEN | Precigen, Inc. | 482.23M | 1.86% | 1,406,805 | 3.93M |
| 167 | VERV | Verve Therapeutics, Inc. | 468.84M | -2.22% | 810,099 | 32.33M |
| 168 | OPT | Opthea Limited | 466.57M | 1.49% | 3,025 | 208.86K |
| 169 | TBPH | Theravance Biopharma, Inc. | 460.57M | 0.11% | 207,038 | 64.38M |
| 170 | PHAT | Phathom Pharmaceuticals, Inc. | 457.44M | 4.21% | 669,864 | 55.25M |
| 171 | ORKA | Oruka Therapeutics, Inc. | 447.41M | 4.92% | 103,001 | - |
| 172 | ORIC | ORIC Pharmaceuticals, Inc. | 446.76M | 7.52% | 1,379,266 | - |
| 173 | KROS | Keros Therapeutics, Inc. | 445.78M | -0.18% | 320,646 | 3.55M |
| 174 | AUTL | Autolus Therapeutics plc | 439.11M | 1.53% | 643,066 | 10.12M |
| 175 | ERAS | Erasca, Inc. | 438.23M | 4.73% | 1,290,028 | - |
| 176 | CRMD | CorMedix Inc. | 437.37M | -6.28% | 2,966,689 | 43.47M |
| 177 | ZVRA | Zevra Therapeutics, Inc. | 430.76M | 1.40% | 350,731 | 23.61M |
| 178 | TRML | Tourmaline Bio, Inc. | 429.72M | -0.65% | 193,708 | - |
| 179 | ALT | Altimmune, Inc. | 428.97M | -0.36% | 1,612,154 | 20.00K |
| 180 | ABVX | ABIVAX Société Anonyme | 426.93M | -3.81% | 104,760 | 11.17M |
| 181 | PRTC | PureTech Health plc | 417.04M | 0.74% | 4,044 | 468.00K |
| 182 | SANA | Sana Biotechnology, Inc. | 415.17M | 1.93% | 3,357,032 | - |
| 183 | EYPT | EyePoint Pharmaceuticals, Inc. | 406.19M | -2.48% | 520,906 | 43.27M |
| 184 | STOK | Stoke Therapeutics, Inc. | 402.88M | 0.68% | 716,439 | 36.56M |
| 185 | RGNX | REGENXBIO Inc. | 396.18M | -3.54% | 470,114 | 83.33M |
| 186 | CELC | Celcuity Inc. | 391.35M | 0.96% | 109,387 | - |
| 187 | TSHA | Taysha Gene Therapies, Inc. | 385.40M | 4.44% | 2,156,906 | 8.33M |
| 188 | ALDX | Aldeyra Therapeutics, Inc. | 373.78M | -0.63% | 1,423,064 | - |
| 189 | MREO | Mereo BioPharma Group plc | 373.30M | 1.69% | 2,732,897 | 1.00M |
| 190 | RNAC | Cartesian Therapeutics, Inc. | 372.03M | -3.49% | 95,224 | 38.91M |
| 191 | UPB | Upstream Bio, Inc. | 365.29M | -0.44% | 338,743 | 2.37M |
| 192 | DNA | Ginkgo Bioworks Holdings, Inc. | 358.27M | -0.90% | 870,698 | 227.04M |
| 193 | ABSI | Absci Corporation | 357.81M | -3.10% | 2,764,807 | 4.53M |
| 194 | TRDA | Entrada Therapeutics, Inc. | 354.84M | 0.61% | 79,332 | 210.78M |
| 195 | RAPP | Rapport Therapeutics, Inc. | 354.02M | - | 192,148 | - |
| 196 | TECX | Tectonic Therapeutic, Inc. | 352.91M | -0.53% | 206,568 | - |
| 197 | HRTX | Heron Therapeutics, Inc. | 351.88M | 0.87% | 705,600 | 144.29M |
| 198 | BNTC | Benitec Biopharma Inc. | 349.91M | -2.03% | 66,238 | - |
| 199 | VSTM | Verastem, Inc. | 346.51M | 5.16% | 815,366 | 10.00M |
| 200 | AMLX | Amylyx Pharmaceuticals, Inc. | 342.89M | 1.57% | 677,949 | 87.37M |
| 201 | ATXS | Astria Therapeutics, Inc. | 341.99M | -0.82% | 168,202 | - |
| 202 | ALLO | Allogene Therapeutics, Inc. | 338.93M | -0.64% | 2,363,658 | 22.00K |
| 203 | SLDB | Solid Biosciences Inc. | 338.64M | 2.58% | 880,870 | - |
| 204 | ZBIO | Zenas BioPharma, Inc. | 335.65M | -0.37% | 174,488 | 5.00M |
| 205 | RIGL | Rigel Pharmaceuticals, Inc. | 328.50M | -3.11% | 183,641 | 179.28M |
| 206 | CADL | Candel Therapeutics, Inc. | 328.29M | -7.33% | 2,428,987 | - |
| 207 | ARCT | Arcturus Therapeutics Holdings Inc. | 325.44M | 0.42% | 261,997 | 152.31M |
| 208 | NNNN | Anbio Biotechnology | 325.23M | -0.87% | 58,168 | 9.50M |
| 209 | GLUE | Monte Rosa Therapeutics, Inc. | 323.54M | -4.55% | 613,647 | 75.62M |
| 210 | PVLA | Palvella Therapeutics, Inc. | 311.50M | -0.61% | 64,018 | - |
| 211 | ATAI | Atai Life Sciences N.V. | 311.34M | 6.80% | 1,849,796 | 308.00K |
| 212 | OABI | OmniAb, Inc. | 301.67M | 1.65% | 636,317 | 26.39M |
| 213 | AURA | Aura Biosciences, Inc. | 296.99M | -0.83% | 405,844 | - |
| 214 | CMPX | Compass Therapeutics, Inc. | 290.39M | 2.94% | 1,162,814 | 850.00K |
| 215 | ATYR | aTyr Pharma, Inc. | 289.68M | 0.62% | 1,273,217 | 235.00K |
| 216 | OLMA | Olema Pharmaceuticals, Inc. | 287.00M | 1.45% | 559,944 | - |
| 217 | IVA | Inventiva S.A. | 283.97M | -0.52% | 5,936 | 15.24M |
| 218 | SEPN | Septerna, Inc. | 279.29M | 2.44% | 239,669 | 1.08M |
| 219 | PROK | ProKidney Corp. | 275.96M | 0.29% | 298,194 | 76.00K |
| 220 | TERN | Terns Pharmaceuticals, Inc. | 272.37M | 0.65% | 540,708 | - |
| 221 | VNDA | Vanda Pharmaceuticals Inc. | 268.25M | -3.56% | 768,932 | 198.77M |
| 222 | SLRN | Acelyrin, Inc. | 265.87M | 3.94% | 445,723 | - |
| 223 | GOSS | Gossamer Bio, Inc. | 263.58M | -1.69% | 1,698,967 | 114.70M |
| 224 | IMMP | Immutep Limited | 261.75M | -0.55% | 89,999 | 3.02M |
| 225 | DRUG | Bright Minds Biosciences Inc. | 259.36M | 1.69% | 31,592 | - |
| 226 | TSVT | 2seventy bio, Inc. | 259.07M | -0.20% | 845,359 | 37.86M |
| 227 | HUMA | Humacyte, Inc. | 258.62M | 0.50% | 5,815,636 | - |
| 228 | AVIR | Atea Pharmaceuticals, Inc. | 258.29M | -5.03% | 164,540 | - |
| 229 | ITOS | iTeos Therapeutics, Inc. | 256.09M | 3.15% | 405,687 | 35.00M |
| 230 | ALMS | Alumis Inc. | 255.71M | -4.47% | 752,227 | - |
| 231 | PRME | Prime Medicine, Inc. | 255.33M | 2.56% | 1,426,789 | 2.98M |
| 232 | MNPR | Monopar Therapeutics Inc. | 252.42M | 8.64% | 25,242 | - |
| 233 | XOMA | XOMA Royalty Corporation | 251.19M | -0.76% | 9,807 | 28.49M |
| 234 | MBX | MBX Biosciences, Inc. | 247.67M | -4.39% | 202,062 | - |
| 235 | ANNX | Annexon, Inc. | 245.75M | -1.97% | 2,691,664 | - |
| 236 | ABEO | Abeona Therapeutics Inc. | 244.61M | 1.00% | 409,373 | - |
| 237 | ENGN | enGene Holdings Inc. | 242.14M | 3.00% | 17,426 | - |
| 238 | ENGNW | enGene Holdings Inc. | 242.14M | -5.00% | 8,001 | - |
| 239 | CDXS | Codexis, Inc. | 241.88M | 3.55% | 929,032 | 59.35M |
| 240 | DSGN | Design Therapeutics, Inc. | 237.84M | 0.96% | 44,180 | - |
| 241 | CDTX | Cidara Therapeutics, Inc. | 236.38M | 3.60% | 64,873 | 1.28M |
| 242 | NGNE | Neurogene Inc. | 228.87M | -5.02% | 165,550 | 925.00K |
| 243 | CRDF | Cardiff Oncology, Inc. | 228.84M | -2.82% | 1,479,224 | 683.00K |
| 244 | NVCT | Nuvectis Pharma, Inc. | 225.73M | 10.29% | 142,099 | - |
| 245 | NTHI | NeOnc Technologies Holdings, Inc. | 224.95M | -0.91% | 9,742 | 83.00K |
| 246 | YMAB | Y-mAbs Therapeutics, Inc. | 224.28M | 2.48% | 196,486 | 87.69M |
| 247 | TENX | Tenax Therapeutics, Inc. | 221.57M | 0.65% | 8,286 | - |
| 248 | CRVS | Corvus Pharmaceuticals, Inc. | 216.55M | 0.60% | 865,326 | - |
| 249 | FHTX | Foghorn Therapeutics Inc. | 215.78M | 1.84% | 69,540 | 22.60M |
| 250 | OCGN | Ocugen, Inc. | 211.39M | -2.04% | 3,122,189 | 4.06M |
| 251 | TVGN | Tevogen Bio Holdings Inc. | 210.06M | 2.56% | 222,616 | - |
| 252 | INBX | Inhibrx Biosciences, Inc. | 207.29M | 0.56% | 43,788 | 200.00K |
| 253 | VYGR | Voyager Therapeutics, Inc. | 206.47M | 2.75% | 214,994 | 80.00M |
| 254 | ELDN | Eledon Pharmaceuticals, Inc. | 204.20M | 1.19% | 265,966 | - |
| 255 | PLX | Protalix BioTherapeutics, Inc. | 201.32M | 4.03% | 169,100 | 53.40M |
| 256 | ACIU | AC Immune SA | 197.89M | 0.50% | 148,506 | 30.14M |
| 257 | CKPT | Checkpoint Therapeutics, Inc. | 196.79M | -0.74% | 1,129,772 | 47.00K |
| 258 | CTNM | Contineum Therapeutics, Inc. | 192.74M | 2.34% | 27,874 | - |
| 259 | SGMO | Sangamo Therapeutics, Inc. | 192.64M | 1.46% | 3,860,493 | 57.80M |
| 260 | CRGX | CARGO Therapeutics, Inc. | 192.04M | 3.22% | 314,868 | - |
| 261 | AARD | Aardvark Therapeutics, Inc. | 190.32M | -5.52% | 145,284 | - |
| 262 | DRTS | Alpha Tau Medical Ltd. | 187.21M | 1.14% | 5,720 | - |
| 263 | RAPT | RAPT Therapeutics, Inc. | 186.79M | -2.41% | 507,414 | - |
| 264 | MDWD | MediWound Ltd. | 183.51M | 2.72% | 101,843 | 20.22M |
| 265 | GNFT | Genfit S.A. | 180.32M | 2.01% | 15,050 | 86.23M |
| 266 | NMRA | Neumora Therapeutics, Inc. | 178.18M | 0.92% | 1,129,678 | - |
| 267 | DMAC | DiaMedica Therapeutics Inc. | 177.42M | 1.47% | 77,953 | - |
| 268 | RZLT | Rezolute, Inc. | 176.76M | 6.96% | 1,303,986 | - |
| 269 | FENC | Fennec Pharmaceuticals Inc. | 176.31M | -0.15% | 38,002 | 47.54M |
| 270 | LYEL | Lyell Immunopharma, Inc. | 175.25M | 6.42% | 790,856 | 61.00K |
| 271 | OBIO | Orchestra BioMed Holdings, Inc. | 174.86M | 5.02% | 25,585 | 2.65M |
| 272 | SLN | Silence Therapeutics plc | 174.26M | 11.14% | 156,496 | 43.26M |
| 273 | TNGX | Tango Therapeutics, Inc. | 174.05M | 4.22% | 1,234,444 | 42.07M |
| 274 | KRRO | Korro Bio, Inc. | 172.57M | 4.05% | 172,793 | 2.27M |
| 275 | NBTX | Nanobiotix S.A. | 172.45M | 1.14% | 2,862 | 45.22M |
| 276 | TNXP | Tonix Pharmaceuticals Holding Corp. | 171.62M | -7.27% | 1,086,158 | 10.09M |
| 277 | IPHA | Innate Pharma S.A. | 169.72M | 3.68% | 14,095 | 20.83M |
| 278 | KLRS | Kalaris Therapeutics, Inc. | 168.51M | -2.17% | 18,670 | - |
| 279 | TARA | Protara Therapeutics, Inc. | 166.92M | 0.22% | 75,032 | - |
| 280 | FULC | Fulcrum Therapeutics, Inc. | 166.80M | 2.32% | 133,740 | 80.00M |
| 281 | FDMT | 4D Molecular Therapeutics, Inc. | 164.84M | -1.39% | 596,945 | 37.00K |
| 282 | IKT | Inhibikase Therapeutics, Inc. | 164.39M | -0.84% | 134,147 | 1.00 |
| 283 | INMB | INmune Bio, Inc. | 164.30M | -4.14% | 353,559 | 42.00K |
| 284 | KOD | Kodiak Sciences Inc. | 160.65M | 1.66% | 311,633 | - |
| 285 | MOLN | Molecular Partners AG | 157.66M | - | 11,958 | 5.48M |
| 286 | THRD | Third Harmonic Bio, Inc. | 157.25M | -1.13% | 257,064 | - |
| 287 | PBYI | Puma Biotechnology, Inc. | 156.27M | 0.64% | 203,167 | 230.47M |
| 288 | LRMR | Larimar Therapeutics, Inc. | 153.67M | 6.67% | 2,166,121 | - |
| 289 | HURA | TuHURA Biosciences, Inc. | 153.20M | 1.69% | 114,095 | - |
| 290 | SCPH | scPharmaceuticals Inc. | 152.86M | 1.00% | 125,192 | 36.33M |
| 291 | PRQR | ProQR Therapeutics N.V. | 150.45M | -5.92% | 2,034,370 | 20.24M |
| 292 | MIST | Milestone Pharmaceuticals Inc. | 149.10M | 11.94% | 7,203,537 | - |
| 293 | ACTU | Actuate Therapeutics, Inc. | 148.05M | -5.25% | 17,597 | - |
| 294 | CYBN | Cybin Inc. | 147.67M | 0.14% | 150,306 | - |
| 295 | ADCT | ADC Therapeutics SA | 146.97M | -3.80% | 512,898 | 70.84M |
| 296 | CGEN | Compugen Ltd. | 142.14M | -0.65% | 123,845 | 27.86M |
| 297 | NKTR | Nektar Therapeutics | 141.03M | -5.46% | 1,847,917 | 98.43M |
| 298 | GLSI | Greenwich LifeSciences, Inc. | 140.78M | 0.75% | 42,089 | - |
| 299 | NKTX | Nkarta, Inc. | 139.79M | 43.80% | 26,989,378 | - |
| 300 | LXEO | Lexeo Therapeutics, Inc. | 136.44M | 3.01% | 321,384 | - |
| 301 | ALEC | Alector, Inc. | 131.78M | 2.69% | 456,328 | 100.56M |
| 302 | MCRB | Seres Therapeutics, Inc. | 131.68M | 3.45% | 1,122,813 | - |
| 303 | CCCC | C4 Therapeutics, Inc. | 130.62M | -0.54% | 749,237 | 35.58M |
| 304 | CSBR | Champions Oncology, Inc. | 130.21M | -0.73% | 21,129 | 58.59M |
| 305 | ZNTL | Zentalis Pharmaceuticals, Inc. | 128.54M | 1.70% | 1,001,069 | 67.43M |
| 306 | TIL | Instil Bio, Inc. | 126.34M | 7.62% | 51,513 | - |
| 307 | LXRX | Lexicon Pharmaceuticals, Inc. | 125.65M | 6.38% | 3,746,958 | 31.08M |
| 308 | ENTA | Enanta Pharmaceuticals, Inc. | 125.01M | - | 98,318 | 66.59M |
| 309 | TLSA | Tiziana Life Sciences Ltd | 124.36M | -3.39% | 126,119 | - |
| 310 | EPRX | Eupraxia Pharmaceuticals Inc. | 122.90M | -1.72% | 12,528 | - |
| 311 | ELTX | Elicio Therapeutics, Inc. | 121.55M | -4.13% | 11,254 | - |
| 312 | SGMT | Sagimet Biosciences Inc. | 121.05M | -4.81% | 302,463 | - |
| 313 | TELO | Telomir Pharmaceuticals, Inc. | 119.65M | -2.43% | 243,639 | - |
| 314 | NAUT | Nautilus Biotechnology, Inc. | 118.20M | 4.09% | 87,274 | - |
| 315 | COYA | Coya Therapeutics, Inc. | 115.08M | 5.70% | 59,742 | 3.55M |
| 316 | LCTX | Lineage Cell Therapeutics, Inc. | 113.40M | -2.60% | 3,107,932 | 9.50M |
| 317 | GNLX | Genelux Corporation | 113.00M | -5.31% | 203,043 | 8.00K |
| 318 | TNYA | Tenaya Therapeutics, Inc. | 112.47M | 7.86% | 1,922,108 | - |
| 319 | IMUX | Immunic, Inc. | 111.70M | 3.33% | 590,962 | - |
| 320 | EDIT | Editas Medicine, Inc. | 107.87M | 2.36% | 1,352,038 | 32.31M |
| 321 | SEER | Seer, Inc. | 107.61M | -1.10% | 68,062 | 14.17M |
| 322 | GALT | Galectin Therapeutics Inc. | 105.44M | 2.44% | 115,810 | - |
| 323 | SLS | SELLAS Life Sciences Group, Inc. | 105.38M | -1.69% | 622,698 | - |
| 324 | VXRT | Vaxart, Inc. | 104.17M | -2.37% | 1,822,063 | 28.70M |
| 325 | ADVM | Adverum Biotechnologies, Inc. | 103.18M | -1.59% | 121,526 | 1.00M |
| 326 | RENB | Renovaro Inc. | 103.09M | -3.84% | 543,479 | - |
| 327 | KYTX | Kyverna Therapeutics, Inc. | 101.67M | -5.80% | 180,786 | - |
| 328 | FATE | Fate Therapeutics, Inc. | 101.03M | 3.22% | 951,887 | 13.63M |
| 329 | ACHV | Achieve Life Sciences, Inc. | 100.59M | -0.68% | 93,831 | - |
| 330 | RGLS | Regulus Therapeutics Inc. | 99.37M | 16.28% | 32,220,606 | - |
| 331 | ANIX | Anixa Biosciences, Inc. | 99.16M | -2.22% | 29,361 | - |
| 332 | XBIT | XBiotech Inc. | 98.78M | 1.57% | 17,012 | - |
| 333 | CHRS | Coherus BioSciences, Inc. | 98.63M | -5.88% | 1,441,927 | 266.96M |
| 334 | CLLS | Cellectis S.A. | 98.06M | - | 96,482 | 49.22M |
| 335 | EXOZ | eXoZymes, Inc. | 96.53M | -19.67% | 42,366 | -700.00 |
| 336 | VOR | Vor Biopharma Inc. | 95.64M | -5.43% | 239,180 | - |
| 337 | AVTX | Avalo Therapeutics, Inc. | 95.46M | 7.00% | 82,922 | 441.00K |
| 338 | BDTX | Black Diamond Therapeutics, Inc. | 94.63M | 5.03% | 2,938,837 | - |
| 339 | MGNX | MacroGenics, Inc. | 93.37M | -5.13% | 949,872 | 149.96M |
| 340 | ORMP | Oramed Pharmaceuticals Inc. | 92.72M | -2.54% | 38,718 | - |
| 341 | ZURA | Zura Bio Limited | 92.65M | 1.12% | 179,037 | - |
| 342 | PLRX | Pliant Therapeutics, Inc. | 92.47M | 2.72% | 1,374,654 | - |
| 343 | CRBU | Caribou Biosciences, Inc. | 91.98M | 12.25% | 1,292,684 | 9.99M |
| 344 | ATOS | Atossa Therapeutics, Inc. | 90.24M | 0.50% | 417,702 | - |
| 345 | BMEA | Biomea Fusion, Inc. | 90.23M | -1.19% | 795,529 | - |
| 346 | CAMP | Camp4 Therapeutics Corporation | 89.11M | -10.16% | 14,943 | - |
| 347 | XCUR | Exicure, Inc. | 88.45M | 0.65% | 19,431 | 500.00K |
| 348 | VIGL | Vigil Neuroscience, Inc. | 88.21M | 5.00% | 147,276 | - |
| 349 | VTYX | Ventyx Biosciences, Inc. | 87.49M | - | 621,914 | - |
| 350 | SNTI | Senti Biosciences, Inc. | 86.48M | -6.32% | 4,988 | - |
| 351 | ARTV | Artiva Biotherapeutics, Inc. | 86.25M | -2.75% | 81,003 | 251.00K |
| 352 | ADVB | Advanced Biomed Inc. | 85.91M | 0.51% | 2,614 | - |
| 353 | CLYM | Climb Bio, Inc. | 85.69M | -2.31% | 65,692 | - |
| 354 | DBVT | DBV Technologies S.A. | 85.27M | -4.40% | 6,977 | 4.20M |
| 355 | ACOG | Alpha Cognition Inc. | 85.07M | -3.80% | 105,958 | - |
| 356 | SAVA | Cassava Sciences, Inc. | 82.12M | -2.86% | 2,407,599 | - |
| 357 | ASMB | Assembly Biosciences, Inc. | 81.79M | 0.83% | 10,134 | 28.52M |
| 358 | TCRX | TScan Therapeutics, Inc. | 81.49M | -0.69% | 829,611 | 2.82M |
| 359 | ANL | Adlai Nortye Ltd. | 80.63M | -1.13% | 14,357 | 5.00M |
| 360 | VERU | Veru Inc. | 80.15M | 3.42% | 2,568,734 | 16.89M |
| 361 | CABA | Cabaletta Bio, Inc. | 78.69M | 2.55% | 591,440 | - |
| 362 | ACRV | Acrivon Therapeutics, Inc. | 78.46M | -3.45% | 519,672 | - |
| 363 | ADAG | Adagene Inc. | 78.44M | -2.35% | 244,043 | 103.20K |
| 364 | CLSD | Clearside Biomedical, Inc. | 78.12M | 0.98% | 140,485 | 7.70M |
| 365 | HLVX | HilleVax, Inc. | 77.66M | - | 84,363 | - |
| 366 | RANI | Rani Therapeutics Holdings, Inc. | 76.95M | -6.29% | 422,108 | - |
| 367 | IGMS | IGM Biosciences, Inc. | 76.51M | 4.07% | 114,599 | 2.68M |
| 368 | THTX | Theratechnologies Inc. | 76.46M | -10.22% | 1,777,063 | 85.87M |
| 369 | IOBT | IO Biotech, Inc. | 76.42M | -3.33% | 147,982 | - |
| 370 | CYCC | Cyclacel Pharmaceuticals, Inc. | 75.34M | 1.87% | 81,549 | 74.00K |
| 371 | VTGN | Vistagen Therapeutics, Inc. | 75.33M | -1.14% | 78,831 | 698.00K |
| 372 | DOMH | Dominari Holdings Inc. | 74.97M | 4.18% | 188,399 | 12.59M |
| 373 | IFRX | InflaRx N.V. | 74.19M | 0.81% | 263,329 | 171.64K |
| 374 | CRVO | CervoMed Inc. | 73.97M | 10.25% | 4,596,322 | 9.74M |
| 375 | ABOS | Acumen Pharmaceuticals, Inc. | 73.90M | 6.03% | 359,589 | - |
| 376 | MNOV | MediciNova, Inc. | 73.57M | 2.04% | 15,061 | - |
| 377 | AVTE | Aerovate Therapeutics, Inc. | 73.33M | 0.80% | 58,195 | - |
| 378 | IVVD | Invivyd, Inc. | 73.18M | -0.89% | 1,646,638 | 25.38M |
| 379 | NTRB | Nutriband Inc. | 72.97M | -0.61% | 7,922 | 2.02M |
| 380 | GNTA | Genenta Science S.p.A. | 72.79M | -3.40% | 2,716 | - |
| 381 | JSPR | Jasper Therapeutics, Inc. | 72.71M | 3.42% | 222,307 | - |
| 382 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 70.82M | -2.20% | 111,477 | - |
| 383 | ACET | Adicet Bio, Inc. | 70.28M | -5.17% | 276,440 | - |
| 384 | CBUS | Cibus, Inc. | 70.08M | 3.03% | 86,939 | 4.26M |
| 385 | IMAB | I-Mab | 68.51M | 0.63% | 60,888 | 569.46K |
| 386 | EPIX | ESSA Pharma Inc. | 68.36M | 0.65% | 44,080 | - |
| 387 | VANI | Vivani Medical, Inc. | 68.12M | 2.68% | 351,934 | - |
| 388 | PYXS | Pyxis Oncology, Inc. | 67.13M | 3.81% | 331,681 | 16.15M |
| 389 | ENTX | Entera Bio Ltd. | 66.15M | -1.32% | 20,300 | 99.00K |
| 390 | CNTX | Context Therapeutics Inc. | 66.07M | -6.88% | 100,770 | - |
| 391 | SKYE | Skye Bioscience, Inc. | 65.67M | -7.83% | 156,265 | - |
| 392 | ANRO | Alto Neuroscience, Inc. | 65.24M | -3.60% | 222,480 | - |
| 393 | UNCY | Unicycive Therapeutics, Inc. | 65.02M | 1.23% | 514,251 | - |
| 394 | INO | Inovio Pharmaceuticals, Inc. | 64.53M | 0.57% | 678,612 | 217.76K |
| 395 | IKNA | Ikena Oncology, Inc. | 64.18M | 2.31% | 34,954 | - |
| 396 | INZY | Inozyme Pharma, Inc. | 63.92M | 3.68% | 397,215 | - |
| 397 | CUE | Cue Biopharma, Inc. | 63.35M | 0.56% | 26,152 | 9.53M |
| 398 | APLT | Applied Therapeutics, Inc. | 63.18M | 3.76% | 1,066,250 | -212.00K |
| 399 | OKUR | OnKure Therapeutics, Inc. | 63.01M | -1.05% | 24,488 | - |
| 400 | STRO | Sutro Biopharma, Inc. | 61.99M | -3.32% | 1,265,096 | 62.04M |
| 401 | GUTS | Fractyl Health, Inc. | 61.64M | -0.79% | 99,396 | 93.00K |
| 402 | QNCX | Quince Therapeutics, Inc. | 61.60M | 4.48% | 128,348 | - |
| 403 | BYSI | BeyondSpring Inc. | 60.45M | - | 12,102 | 1.88M |
| 404 | PMVP | PMV Pharmaceuticals, Inc. | 59.72M | -0.86% | 36,642 | - |
| 405 | ARMP | Armata Pharmaceuticals, Inc. | 59.70M | -1.79% | 9,700 | 5.17M |
| 406 | IMRX | Immuneering Corporation | 59.57M | 1.22% | 94,028 | - |
| 407 | ALGS | Aligos Therapeutics, Inc. | 59.06M | - | 98,644 | 3.95M |
| 408 | ATNM | Actinium Pharmaceuticals, Inc. | 58.96M | 1.07% | 1,495,766 | 81.00K |
| 409 | MGX | Metagenomi, Inc. | 57.57M | -3.14% | 416,633 | 52.30M |
| 410 | ANEB | Anebulo Pharmaceuticals, Inc. | 57.52M | -9.68% | 14,055 | - |
| 411 | ADAP | Adaptimmune Therapeutics plc | 56.59M | -4.37% | 1,862,243 | 178.03M |
| 412 | GANX | Gain Therapeutics, Inc. | 54.91M | -1.91% | 149,876 | - |
| 413 | VTVT | vTv Therapeutics Inc. | 54.70M | -0.35% | 2,420 | 1.02M |
| 414 | STTK | Shattuck Labs, Inc. | 54.42M | -3.39% | 143,346 | 5.72M |
| 415 | ONCY | Oncolytics Biotech Inc. | 54.34M | -1.46% | 100,752 | - |
| 416 | OSRH | OSR Holdings, Inc. | 53.31M | -21.11% | 1,766,374 | - |
| 417 | PEPG | PepGen Inc. | 52.63M | 2.55% | 391,737 | - |
| 418 | PSTV | Plus Therapeutics, Inc. | 51.59M | 3.40% | 15,258,223 | 5.73M |
| 419 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 50.77M | 0.92% | 293,373 | - |
| 420 | FBRX | Forte Biosciences, Inc. | 50.57M | -3.54% | 65,627 | - |
| 421 | KRON | Kronos Bio, Inc. | 50.30M | -4.38% | 101,374 | 9.85M |
| 422 | CTMX | CytomX Therapeutics, Inc. | 49.39M | 3.79% | 632,975 | 138.10M |
| 423 | OKYO | OKYO Pharma Limited | 48.53M | 8.33% | 56,191 | - |
| 424 | MAIA | MAIA Biotechnology, Inc. | 48.23M | -1.21% | 46,403 | - |
| 425 | HOWL | Werewolf Therapeutics, Inc. | 47.97M | 3.88% | 142,721 | 1.89M |
| 426 | FBIO | Fortress Biotech, Inc. | 47.76M | 2.98% | 233,281 | 81.50M |
| 427 | LSB | LakeShore Biopharma Co., Ltd | 47.72M | -7.03% | 4,696 | 79.42M |
| 428 | IMMX | Immix Biopharma, Inc. | 47.40M | -6.56% | 57,800 | - |
| 429 | IPSC | Century Therapeutics, Inc. | 47.19M | -1.37% | 274,696 | 6.59M |
| 430 | SER | Serina Therapeutics, Inc. | 47.18M | -2.06% | 413 | 56.00K |
| 431 | XFOR | X4 Pharmaceuticals, Inc. | 47.08M | 0.63% | 1,293,313 | 2.56M |
| 432 | SPRO | Spero Therapeutics, Inc. | 46.89M | -1.48% | 77,714 | 106.46M |
| 433 | WHWK | Whitehawk Therapeutics, Inc. | 46.83M | -1.04% | 204,417 | 25.98M |
| 434 | PDSB | PDS Biotechnology Corporation | 46.76M | 0.81% | 251,178 | - |
| 435 | MRSN | Mersana Therapeutics, Inc. | 46.39M | -9.24% | 6,044,159 | 40.50M |
| 436 | RPTX | Repare Therapeutics Inc. | 45.49M | 5.94% | 382,835 | 53.48M |
| 437 | OTLK | Outlook Therapeutics, Inc. | 44.82M | 8.53% | 251,678 | - |
| 438 | ITRM | Iterum Therapeutics plc | 44.61M | -3.01% | 241,297 | - |
| 439 | IRD | Opus Genetics, Inc. | 44.53M | -3.85% | 121,023 | 8.38M |
| 440 | ICCC | ImmuCell Corporation | 43.67M | 2.51% | 36,150 | 26.49M |
| 441 | IBIO | iBio, Inc. | 43.55M | 2.32% | 819,953 | 375.00K |
| 442 | ANTX | AN2 Therapeutics, Inc. | 43.03M | -5.26% | 46,066 | - |
| 443 | BRNS | Barinthus Biotherapeutics plc | 42.36M | - | 5,374 | 14.97M |
| 444 | CELU | Celularity Inc. | 42.27M | -6.47% | 47,531 | 48.20M |
| 445 | AGEN | Agenus Inc. | 42.01M | -0.60% | 476,685 | 103.46M |
| 446 | CNTB | Connect Biopharma Holdings Limited | 41.99M | -2.28% | 17,261 | 24.12M |
| 447 | RADX | Radiopharm Theranostics Limited | 41.21M | 3.64% | 9,706 | 204.61K |
| 448 | ATRA | Atara Biotherapeutics, Inc. | 40.31M | 3.93% | 18,958 | 128.94M |
| 449 | LTRN | Lantern Pharma Inc. | 40.12M | 1.92% | 16,855 | - |
| 450 | DYAI | Dyadic International, Inc. | 39.95M | 1.50% | 74,473 | 3.50M |
| 451 | VRCA | Verrica Pharmaceuticals Inc. | 39.87M | -2.27% | 249,071 | 7.57M |
| 452 | KALA | KALA BIO, Inc. | 38.50M | -6.37% | 29,340 | - |
| 453 | RNTX | Rein Therapeutics Inc. | 38.35M | 1.14% | 1,181 | - |
| 454 | ALXO | ALX Oncology Holdings Inc. | 38.13M | 5.09% | 429,113 | - |
| 455 | FBLG | FibroBiologics, Inc. | 37.88M | -1.92% | 49,827 | - |
| 456 | XLO | Xilio Therapeutics, Inc. | 37.79M | -0.41% | 336,154 | 6.34M |
| 457 | PRLD | Prelude Therapeutics Incorporated | 37.60M | 6.61% | 129,908 | 7.00M |
| 458 | KZR | Kezar Life Sciences, Inc. | 37.48M | -0.77% | 7,833 | - |
| 459 | SRZN | Surrozen, Inc. | 37.02M | 2.25% | 5,838 | 10.00M |
| 460 | BLUE | bluebird bio, Inc. | 36.92M | 1.07% | 171,105 | 83.81M |
| 461 | TPST | Tempest Therapeutics, Inc. | 36.66M | 4.84% | 371,428 | - |
| 462 | KPTI | Karyopharm Therapeutics Inc. | 36.61M | -10.31% | 186,718 | 145.24M |
| 463 | INKT | MiNK Therapeutics, Inc. | 36.49M | 7.85% | 6,720 | - |
| 464 | RNXT | RenovoRx, Inc. | 36.28M | 0.99% | 53,474 | - |
| 465 | ANVS | Annovis Bio, Inc. | 36.05M | - | 163,193 | - |
| 466 | CVKD | Cadrenal Therapeutics, Inc. | 35.17M | 1.41% | 25,684 | - |
| 467 | NRXP | NRx Pharmaceuticals, Inc. | 35.02M | - | 112,686 | - |
| 468 | DTIL | Precision BioSciences, Inc. | 34.83M | 0.22% | 65,749 | 68.70M |
| 469 | ATHE | Alterity Therapeutics Limited | 34.65M | -3.04% | 10,720 | 2.30M |
| 470 | OSTX | OS Therapies Incorporated | 34.41M | -0.61% | 92,471 | - |
| 471 | LVTX | LAVA Therapeutics N.V. | 34.19M | 1.96% | 22,439 | 7.35M |
| 472 | CASI | CASI Pharmaceuticals, Inc. | 34.08M | 4.27% | 2,743 | 22.06M |
| 473 | BOLD | Boundless Bio, Inc. | 33.67M | -0.66% | 78,729 | - |
| 474 | ESLA | Estrella Immunopharma, Inc. | 33.65M | -1.06% | 2,685 | - |
| 475 | FGEN | FibroGen, Inc. | 32.59M | -5.06% | 1,653,943 | 29.62M |
| 476 | AKTX | Akari Therapeutics, Plc | 32.19M | -0.76% | 2,957 | - |
| 477 | GRCE | Grace Therapeutics, Inc. | 31.14M | -5.81% | 11,376 | - |
| 478 | LEXX | Lexaria Bioscience Corp. | 30.72M | -1.13% | 19,960 | 496.92K |
| 479 | ASBP | Aspire Biopharma Holdings, Inc. | 30.70M | 3.69% | 175,811 | - |
| 480 | GBIO | Generation Bio Co. | 30.62M | 0.24% | 179,640 | 19.89M |
| 481 | PLUR | Pluri Inc. | 30.51M | 0.69% | 2,057 | 678.00K |
| 482 | CLGN | CollPlant Biotechnologies Ltd. | 30.35M | -2.93% | 3,269 | 515.00K |
| 483 | RLYB | Rallybio Corporation | 29.34M | 4.60% | 19,495 | 636.00K |
| 484 | INTS | Intensity Therapeutics, Inc. | 29.28M | -1.58% | 5,913 | - |
| 485 | CGTX | Cognition Therapeutics, Inc. | 27.93M | 2.06% | 248,406 | - |
| 486 | CALC | CalciMedica, Inc. | 27.91M | 4.02% | 22,073 | - |
| 487 | PYPD | PolyPid Ltd. | 27.72M | -1.81% | 43,929 | - |
| 488 | OVID | Ovid Therapeutics Inc. | 26.93M | -6.90% | 487,997 | 566.00K |
| 489 | COEP | Coeptis Therapeutics Holdings, Inc. | 26.52M | -1.38% | 10,718 | - |
| 490 | VYNE | VYNE Therapeutics Inc. | 26.40M | 4.09% | 220,851 | 501.00K |
| 491 | PULM | Pulmatrix, Inc. | 26.37M | 6.96% | 14,989 | 7.81M |
| 492 | IBO | Impact BioMedical Inc. | 26.23M | 3.64% | 2,457,028 | - |
| 493 | GDTC | CytoMed Therapeutics Limited | 25.97M | -2.60% | 5,148 | 330.25K |
| 494 | PASG | Passage Bio, Inc. | 25.68M | -10.19% | 185,112 | - |
| 495 | LGVN | Longeveron Inc. | 25.38M | -1.16% | 153,547 | 2.39M |
| 496 | DARE | Daré Bioscience, Inc. | 25.14M | 0.35% | 11,156 | 1.88M |
| 497 | CARA | Cara Therapeutics, Inc. | 24.61M | -0.37% | 8,418 | 7.14M |
| 498 | JUNS | Jupiter Neurosciences, Inc. | 24.59M | -0.83% | 84,027 | - |
| 499 | NRSN | NeuroSense Therapeutics Ltd. | 24.16M | -4.59% | 152,092 | - |
| 500 | MLEC | Moolec Science SA | 24.14M | 0.62% | 37,581 | 5.44M |
| 501 | IGC | IGC Pharma, Inc. | 23.91M | -3.23% | 195,304 | 1.24M |
| 502 | MURA | Mural Oncology plc | 23.26M | 1.50% | 466,007 | - |
| 503 | QTTB | Q32 Bio Inc. | 23.05M | -5.03% | 150,372 | - |
| 504 | PMN | ProMIS Neurosciences, Inc. | 22.88M | -2.74% | 8,993 | - |
| 505 | BCAB | BioAtla, Inc. | 22.78M | 4.81% | 1,152,540 | 11.00M |
| 506 | ENLV | Enlivex Therapeutics Ltd. | 22.21M | -3.81% | 23,398 | - |
| 507 | CDIO | Cardio Diagnostics Holdings, Inc. | 21.55M | -3.37% | 766,852 | 34.89K |
| 508 | CMMB | Chemomab Therapeutics Ltd. | 21.31M | -2.59% | 1,195,214 | - |
| 509 | ALLK | Allakos Inc. | 21.07M | 2.17% | 309,783 | - |
| 510 | ABP | Abpro Holdings, Inc. | 20.80M | -1.53% | 44,586 | 230.00K |
| 511 | CRIS | Curis, Inc. | 20.41M | 0.84% | 69,338 | 10.26M |
| 512 | LSTA | Lisata Therapeutics, Inc. | 20.27M | 0.02% | 1,846 | 1.00M |
| 513 | IPA | ImmunoPrecise Antibodies Ltd. | 20.15M | 2.99% | 411,689 | 17.27M |
| 514 | BIVI | BioVie Inc. | 19.93M | 3.35% | 120,387 | - |
| 515 | UBX | Unity Biotechnology, Inc. | 19.90M | -1.67% | 248,022 | - |
| 516 | NNVC | NanoViricides, Inc. | 18.93M | -4.72% | 104,969 | - |
| 517 | CVM | CEL-SCI Corporation | 18.45M | -0.38% | 2,365,216 | - |
| 518 | PTN | Palatin Technologies, Inc. | 18.20M | -2.78% | 450,200 | 350.00K |
| 519 | LPCN | Lipocine Inc. | 17.72M | -4.54% | 5,245 | 11.20M |
| 520 | GOVX | GeoVax Labs, Inc. | 17.58M | -7.30% | 314,936 | 3.09M |
| 521 | EDSA | Edesa Biotech, Inc. | 17.55M | -0.39% | 5,707 | - |
| 522 | EQ | Equillium, Inc. | 17.29M | -34.81% | 1,294,097 | 41.10M |
| 523 | INAB | IN8bio, Inc. | 16.91M | -0.43% | 497,820 | - |
| 524 | BOLT | Bolt Biotherapeutics, Inc. | 16.85M | -2.05% | 235,343 | 7.69M |
| 525 | CLRB | Cellectar Biosciences, Inc. | 16.60M | -0.99% | 243,465 | - |
| 526 | IMNN | Imunon, Inc. | 16.53M | 8.57% | 350,354 | - |
| 527 | ICU | SeaStar Medical Holding Corporation | 15.75M | -9.47% | 237,770 | 68.00K |
| 528 | GLYC | GlycoMimetics, Inc. | 15.62M | -0.82% | 74,600 | - |
| 529 | MEIP | MEI Pharma, Inc. | 15.59M | 0.86% | 10,140 | - |
| 530 | CANF | Can-Fite BioPharma Ltd. | 15.55M | 1.32% | 51,979 | 667.00K |
| 531 | ELEV | Elevation Oncology, Inc. | 15.40M | -1.14% | 944,277 | - |
| 532 | NRXS | NeurAxis, Inc. | 15.38M | -0.93% | 3,763 | 2.69M |
| 533 | BCTX | BriaCell Therapeutics Corp. | 15.06M | 0.75% | 36,874 | - |
| 534 | HOOK | HOOKIPA Pharma Inc. | 15.05M | -1.64% | 46,432 | 43.95M |
| 535 | SYBX | Synlogic, Inc. | 14.97M | -2.29% | 1,094 | 8.00K |
| 536 | NXTC | NextCure, Inc. | 14.86M | -0.15% | 25,534 | - |
| 537 | CARM | Carisma Therapeutics, Inc. | 14.85M | -7.61% | 110,585 | 20.27M |
| 538 | SLGL | Sol-Gel Technologies Ltd. | 14.74M | -9.73% | 16,116 | 11.71M |
| 539 | MBRX | Moleculin Biotech, Inc. | 14.70M | -1.87% | 399,107 | - |
| 540 | MRKR | Marker Therapeutics, Inc. | 14.67M | 15.95% | 148,940 | 5.40M |
| 541 | COCP | Cocrystal Pharma, Inc. | 14.55M | -4.03% | 16,905 | - |
| 542 | CING | Cingulate Inc. | 14.36M | 6.10% | 197,515 | - |
| 543 | SABS | SAB Biotherapeutics, Inc. | 14.31M | 1.31% | 17,583 | 1.51M |
| 544 | LPTX | Leap Therapeutics, Inc. | 13.98M | -19.56% | 4,335,815 | - |
| 545 | MTVA | MetaVia Inc. | 13.50M | - | 28,719 | - |
| 546 | HCWB | HCW Biologics Inc. | 13.47M | 0.10% | 81,136 | 3.50M |
| 547 | CLDI | Calidi Biotherapeutics, Inc. | 13.43M | 3.64% | 147,987 | - |
| 548 | KAPA | Kairos Pharma, Ltd. | 13.29M | 1.04% | 56,348 | - |
| 549 | AFMD | Affimed N.V. | 13.20M | -2.84% | 69,834 | 6.29M |
| 550 | SPRB | Spruce Biosciences, Inc. | 13.11M | -3.42% | 46,319 | 7.10M |
| 551 | BRTX | BioRestorative Therapies, Inc. | 12.66M | 3.98% | 23,682 | 377.00K |
| 552 | NERV | Minerva Neurosciences, Inc. | 12.66M | - | 3,374 | - |
| 553 | BCDA | BioCardia, Inc. | 12.29M | 5.10% | 49,279 | 58.00K |
| 554 | RNAZ | TransCode Therapeutics, Inc. | 12.14M | -11.86% | 3,037,701 | - |
| 555 | APRE | Aprea Therapeutics, Inc. | 12.08M | -1.79% | 5,714 | 1.50M |
| 556 | ERNA | Eterna Therapeutics Inc. | 11.82M | -1.48% | 158,911 | 582.00K |
| 557 | CSCI | COSCIENS Biopharma Inc. | 11.81M | -3.00% | 491 | 4.83M |
| 558 | ATHA | Athira Pharma, Inc. | 11.75M | -4.11% | 47,285 | - |
| 559 | BLRX | BioLineRx Ltd. | 11.55M | 0.63% | 16,770 | 21.99M |
| 560 | DWTX | Dogwood Therapeutics, Inc. | 11.43M | 0.34% | 23,386 | - |
| 561 | CTXR | Citius Pharmaceuticals, Inc. | 11.17M | -4.41% | 130,395 | - |
| 562 | EVAX | Evaxion Biotech A/S | 11.03M | -0.56% | 48,111 | 3.30M |
| 563 | SNSE | Sensei Biotherapeutics, Inc. | 10.84M | -1.19% | 61,316 | - |
| 564 | XTLB | XTL Biopharmaceuticals Ltd. | 10.56M | -0.82% | 3,856 | 46.00K |
| 565 | NEUP | Neuphoria Therapeutics Inc. | 10.19M | 4.50% | 98,172 | 662.72K |
| 566 | IMRN | Immuron Limited | 10.17M | -0.55% | 331 | 4.05M |
| 567 | PHGE | BiomX Inc. | 10.16M | 7.50% | 44,100 | - |
| 568 | LYRA | Lyra Therapeutics, Inc. | 10.06M | -2.05% | 275,623 | 1.53M |
| 569 | SLXN | Silexion Therapeutics Corp | 9.93M | 1.72% | 177,171 | - |
| 570 | PMCB | PharmaCyte Biotech, Inc. | 9.51M | -7.38% | 73,921 | - |
| 571 | TSBX | Turnstone Biologics Corp. | 9.43M | 1.98% | 24,605 | - |
| 572 | TRAW | Traws Pharma, Inc. | 9.38M | 0.39% | 20,662 | 226.00K |
| 573 | INDP | Indaptus Therapeutics, Inc. | 9.38M | 2.75% | 121,103 | - |
| 574 | ACXP | Acurx Pharmaceuticals, Inc. | 9.34M | -2.55% | 91,069 | - |
| 575 | APLM | Apollomics, Inc. | 9.26M | -3.45% | 3,792 | 2.10M |
| 576 | EVGN | Evogene Ltd. | 9.09M | - | 10,095 | 8.51M |
| 577 | KPRX | Kiora Pharmaceuticals, Inc. | 9.06M | 1.00% | 9,341 | 16.02M |
| 578 | RLMD | Relmada Therapeutics, Inc. | 8.99M | -2.90% | 248,828 | - |
| 579 | CHRO | Channel Therapeutics Corporation | 8.92M | 1.86% | 11,690 | - |
| 580 | ABVC | ABVC BioPharma, Inc. | 8.63M | 2.47% | 52,075 | 509.79K |
| 581 | AIM | AIM ImmunoTech Inc. | 8.16M | -1.62% | 257,858 | 190.00K |
| 582 | PRTG | Portage Biotech Inc. | 7.75M | 3.74% | 5,291 | - |
| 583 | DRMA | Dermata Therapeutics, Inc. | 7.71M | 5.19% | 75,696,902 | - |
| 584 | BCLI | Brainstorm Cell Therapeutics Inc. | 7.70M | -3.57% | 15,694 | - |
| 585 | APTO | Aptose Biosciences Inc. | 7.69M | 6.32% | 17,088 | - |
| 586 | PPBT | Purple Biotech Ltd | 7.50M | 0.92% | 10,532 | - |
| 587 | ALZN | Alzamend Neuro, Inc. | 7.26M | 10.00% | 173,850 | - |
| 588 | SNGX | Soligenix, Inc. | 7.23M | -1.72% | 38,647 | 119.37K |
| 589 | BTAI | BioXcel Therapeutics, Inc. | 7.17M | 5.96% | 210,016 | 2.28M |
| 590 | KLTO | Klotho Neurosciences, Inc. | 7.10M | 2.62% | 248,423 | - |
| 591 | HOTH | Hoth Therapeutics, Inc. | 6.90M | -1.96% | 107,795 | - |
| 592 | AEON | AEON Biopharma, Inc. | 6.74M | -8.57% | 360,520 | - |
| 593 | CYCN | Cyclerion Therapeutics, Inc. | 6.64M | 1.56% | 6,584 | 2.00M |
| 594 | APM | Aptorum Group Limited | 6.28M | -0.05% | 8,801 | - |
| 595 | PHIO | Phio Pharmaceuticals Corp. | 6.26M | 0.77% | 31,668 | - |
| 596 | ADXN | Addex Therapeutics Ltd | 6.12M | 0.38% | 1,015 | 701.26K |
| 597 | NCNA | NuCana plc | 6.06M | 28.92% | 246,645 | - |
| 598 | SILO | Silo Pharma, Inc. | 5.92M | -2.94% | 44,532 | 72.10K |
| 599 | QNRX | Quoin Pharmaceuticals, Ltd. | 5.87M | -3.39% | 164,321 | - |
| 600 | CMND | Clearmind Medicine Inc. | 5.39M | -2.78% | 22,548 | - |
| 601 | VRAX | Virax Biolabs Group Limited | 5.38M | -2.36% | 40,757 | 84.87K |
| 602 | KZIA | Kazia Therapeutics Limited | 5.31M | -4.04% | 22,585 | 1.66M |
| 603 | GTBP | GT Biopharma, Inc. | 5.14M | -4.56% | 14,557 | - |
| 604 | XBIO | Xenetic Biosciences, Inc. | 5.03M | -0.91% | 6,762 | 2.50M |
| 605 | OGEN | Oragenics, Inc. | 4.94M | -8.00% | 513,200 | - |
| 606 | AZTR | Azitra, Inc. | 4.90M | 3.48% | 188,363 | 7.50K |
| 607 | ALLR | Allarity Therapeutics, Inc. | 4.66M | -7.89% | 3,274,826 | - |
| 608 | GLTO | Galecto, Inc. | 4.54M | -12.94% | 80,916 | - |
| 609 | ENSC | Ensysce Biosciences, Inc. | 4.38M | -2.50% | 6,172 | 5.21M |
| 610 | ADIL | Adial Pharmaceuticals, Inc. | 4.27M | -6.49% | 85,365 | - |
| 611 | ELAB | PMGC Holdings Inc. | 4.26M | -4.31% | 68,428 | 2.45M |
| 612 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 4.02M | -1.50% | 23,905 | 1.00M |
| 613 | CELZ | Creative Medical Technology Holdings, Inc. | 3.86M | - | 118,174 | 11.00K |
| 614 | MBIO | Mustang Bio, Inc. | 3.74M | 0.71% | 23,479 | - |
| 615 | SNPX | Synaptogenix, Inc. | 3.62M | - | 8,358 | - |
| 616 | KTTA | Pasithea Therapeutics Corp. | 3.57M | -2.22% | 34,122 | - |
| 617 | ONVO | Organovo Holdings, Inc. | 3.45M | -13.50% | 226,336 | 122.00K |
| 618 | XRTX | XORTX Therapeutics Inc. | 3.38M | -1.04% | 6,900 | - |
| 619 | TOVX | Theriva Biologics, Inc. | 3.37M | 0.83% | 16 | - |
| 620 | LIXT | Lixte Biotechnology Holdings, Inc. | 3.36M | 2.47% | 6,476 | - |
| 621 | TTNP | Titan Pharmaceuticals, Inc. | 3.32M | 4.31% | 21,798 | - |
| 622 | LIPO | Lipella Pharmaceuticals Inc. | 3.29M | 5.19% | 13,416 | 483.53K |
| 623 | ATNF | 180 Life Sciences Corp. | 3.27M | -2.83% | 26,036 | - |
| 624 | ARTL | Artelo Biosciences, Inc. | 3.17M | -0.63% | 9,766 | - |
| 625 | GRI | GRI Bio, Inc. | 3.08M | -2.17% | 7,643 | - |
| 626 | ENVB | Enveric Biosciences, Inc. | 3.05M | -1.23% | 68,986 | - |
| 627 | PALI | Palisade Bio, Inc. | 3.03M | -1.09% | 73,001 | - |
| 628 | NBY | NovaBay Pharmaceuticals, Inc. | 2.98M | -0.16% | 48,750 | 13.84M |
| 629 | GNPX | Genprex, Inc. | 2.91M | -10.00% | 1,629,694 | - |
| 630 | MTNB | Matinas BioPharma Holdings, Inc. | 2.90M | 1.93% | 9,596 | - |
| 631 | PBM | Psyence Biomedical Ltd. | 2.90M | 6.16% | 165,645 | - |
| 632 | THAR | Tharimmune, Inc. | 2.87M | -4.90% | 25,265 | - |
| 633 | JAGX | Jaguar Health, Inc. | 2.82M | 4.87% | 36,079 | 10.48M |
| 634 | CDT | Conduit Pharmaceuticals Inc. | 2.80M | -9.65% | 378,436 | - |
| 635 | QLGN | Qualigen Therapeutics, Inc. | 2.78M | 18.12% | 31,405 | - |
| 636 | OCEA | Ocean Biomedical, Inc. | 2.72M | -6.81% | 214,472,622 | - |
| 637 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.68M | -3.19% | 27,864 | 462.61K |
| 638 | EYEN | Eyenovia, Inc. | 2.64M | - | 61,207 | 31.83K |
| 639 | ENTO | Entero Therapeutics, Inc. | 2.54M | -2.84% | 27,536 | - |
| 640 | GLMD | Galmed Pharmaceuticals Ltd. | 2.53M | -3.45% | 54,099 | - |
| 641 | REVB | Revelation Biosciences, Inc. | 2.50M | -0.36% | 12,444 | - |
| 642 | NLSP | NLS Pharmaceutics AG | 2.48M | -0.65% | 2,592 | - |
| 643 | SCNI | Scinai Immunotherapeutics Ltd. | 2.47M | -14.83% | 144,506 | 452.00K |
| 644 | TCRT | Alaunos Therapeutics, Inc. | 2.43M | -4.40% | 3,561 | 7.00K |
| 645 | PLRZ | Polyrizon Ltd. | 2.09M | 6.09% | 368,546 | - |
| 646 | PCSA | Processa Pharmaceuticals, Inc. | 2.00M | -2.09% | 145,373 | - |
| 647 | ADTX | Aditxt, Inc. | 1.95M | -10.00% | 196,772 | 212.11K |
| 648 | APVO | Aptevo Therapeutics Inc. | 1.82M | -18.83% | 172,973 | - |
| 649 | PTIX | Protagenic Therapeutics, Inc. | 1.70M | -4.94% | 22,900 | - |
| 650 | ZVSA | ZyVersa Therapeutics, Inc. | 1.64M | -4.63% | 120,356 | - |
| 651 | SLRX | Salarius Pharmaceuticals, Inc. | 1.61M | 6.17% | 254,345 | - |
| 652 | VRPX | Virpax Pharmaceuticals, Inc. | 1.57M | -4.52% | 246,240 | - |
| 653 | CNSP | CNS Pharmaceuticals, Inc. | 1.52M | -6.38% | 358,446 | - |
| 654 | CERO | CERo Therapeutics Holdings, Inc. | 1.47M | -9.51% | 5,310,076 | - |
| 655 | VINC | Vincerx Pharma, Inc. | 1.27M | -5.97% | 310,237 | - |
| 656 | WINT | Windtree Therapeutics, Inc. | 1.23M | -3.53% | 365,521 | - |
| 657 | SPRC | SciSparc Ltd. | 1.12M | -0.99% | 178,051 | 1.75M |
| 658 | TNFA | TNF Pharmaceuticals, Inc. | 989.07K | -1.23% | 81,551 | - |
| 659 | ONCO | Onconetix, Inc. | 893.34K | 1.60% | 68,473,861 | 1.87M |
| 660 | BDRX | Biodexa Pharmaceuticals Plc | 862.48K | -13.42% | 159,144 | 104.90K |
| 661 | SCPX | Scorpius Holdings, Inc. | 754.58K | -3.13% | 274,545 | 10.04M |
| 662 | HEPA | Hepion Pharmaceuticals, Inc. | 129.56K | -10.95% | 1,424,575 | - |